Our clinic remains open for participant study visits during all alert levels.  ||  Our US Toll Free #: 1844 264 6291

VEITHsymposium November 2022

49th Annual Symposium on Vascular and Endovascular Issues

AusBiotech 2022

Australia's largest Life Sciences Conference

2022 ANZSVS Conference

21-24 October 2022 Hobart Australia

2022 ARCS Annual Conference

The 2022 ARCS Annual Conference was held on 23-25 May at the ICC Sydney!

ANZSVS 2021 ASC in association with ANZSVN and the WFVS

Virtual Conference 08 - 11 October 2021

Clinical Feasibility Study for Endovenous Deep Vein Valve Formation for Chronic Venous Insufficiency

Initial Results. Mr. Thodur Vasudevan, Clinical Trials NZ

SABER™ Bupivacaine, a novel extended-release formulation of bupivacaine for postoperative pain control...

demonstrates dose-response, safety and no impact on surgical wound healing.

SABER™ Bupivacaine Reduces Postoperative Pain Intensity and Opioid Use for 72 Hours in Soft-Tissue and Bony Surgeries

Poster presentation American Society of Anaesthesiologists, October 15 2014

Intranasal Ketorolac (ROX-888) for Postoperative Pain: A Phase 3, Double-Blind, Randomized Study

Presented at the 2008 Society for Ambulatory Anesthesia Annual Meeting